BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

493 related articles for article (PubMed ID: 11684952)

  • 21. Inflammatory myofibroblastic tumor of the central nervous system and its relationship to inflammatory pseudotumor.
    Swain RS; Tihan T; Horvai AE; Di Vizio D; Loda M; Burger PC; Scheithauer BW; Kim GE
    Hum Pathol; 2008 Mar; 39(3):410-9. PubMed ID: 18261625
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ALK Is a Specific Diagnostic Marker for Inflammatory Myofibroblastic Tumor of the Uterus.
    Mohammad N; Haimes JD; Mishkin S; Kudlow BA; Leong MY; Chew SH; Koay E; Whitehouse A; Cope N; Ali RH; Köbel M; Stewart CJR; McCluggage WG; Lee CH
    Am J Surg Pathol; 2018 Oct; 42(10):1353-1359. PubMed ID: 30015720
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Uterine Inflammatory Myofibroblastic Tumors Frequently Harbor ALK Fusions With IGFBP5 and THBS1.
    Haimes JD; Stewart CJR; Kudlow BA; Culver BP; Meng B; Koay E; Whitehouse A; Cope N; Lee JC; Ng T; McCluggage WG; Lee CH
    Am J Surg Pathol; 2017 Jun; 41(6):773-780. PubMed ID: 28490045
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Inflammatory myofibroblastic tumor].
    Leuschner I
    Pathologe; 2010 Mar; 31(2):106-8. PubMed ID: 20063099
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expanding the Molecular Characterization of Thoracic Inflammatory Myofibroblastic Tumors beyond ALK Gene Rearrangements.
    Chang JC; Zhang L; Drilon AE; Chi P; Alaggio R; Borsu L; Benayed R; Travis WD; Ladanyi M; Antonescu CR
    J Thorac Oncol; 2019 May; 14(5):825-834. PubMed ID: 30550870
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ALK1 and p80 expression and chromosomal rearrangements involving 2p23 in inflammatory myofibroblastic tumor.
    Coffin CM; Patel A; Perkins S; Elenitoba-Johnson KS; Perlman E; Griffin CA
    Mod Pathol; 2001 Jun; 14(6):569-76. PubMed ID: 11406658
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ALK-1-positive inflammatory myofibroblastic tumor of the thyroid complicated by Hashimoto's thyroiditis: report of a rare case and a literature review.
    Li CF; Wu XL; Wang JJ; Wang K; Zhang SY; Huang JJ; Hu HZ; Zheng H
    Diagn Pathol; 2020 May; 15(1):58. PubMed ID: 32430041
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anaplastic lymphoma kinase (ALK 1) staining and molecular analysis in inflammatory myofibroblastic tumours of the bladder: a preliminary clinicopathological study of nine cases and review of the literature.
    Freeman A; Geddes N; Munson P; Joseph J; Ramani P; Sandison A; Fisher C; Parkinson MC
    Mod Pathol; 2004 Jul; 17(7):765-71. PubMed ID: 15105807
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intraocular inflammatory myofibroblastic tumor with ALK overexpression.
    O'Malley DP; Poulos C; Czader M; Sanger WG; Orazi A
    Arch Pathol Lab Med; 2004 Jan; 128(1):e5-7. PubMed ID: 14692830
    [TBL] [Abstract][Full Text] [Related]  

  • 30. For staining of ALK protein, the novel D5F3 antibody demonstrates superior overall performance in terms of intensity and extent of staining in comparison to the currently used ALK1 antibody.
    Taheri D; Zahavi DJ; Del Carmen Rodriguez M; Meliti A; Rezaee N; Yonescu R; Ricardo BF; Dolatkhah S; Ning Y; Bishop JA; Netto GJ; Sharma R
    Virchows Arch; 2016 Sep; 469(3):345-50. PubMed ID: 27271275
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Crizotinib in ALK-rearranged inflammatory myofibroblastic tumor.
    Butrynski JE; D'Adamo DR; Hornick JL; Dal Cin P; Antonescu CR; Jhanwar SC; Ladanyi M; Capelletti M; Rodig SJ; Ramaiya N; Kwak EL; Clark JW; Wilner KD; Christensen JG; Jänne PA; Maki RG; Demetri GD; Shapiro GI
    N Engl J Med; 2010 Oct; 363(18):1727-33. PubMed ID: 20979472
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Abdominal inflammatory myofibroblastic tumour: Clinicopathological and molecular analysis of 20 cases, highlighting potential therapeutic targets.
    Vernemmen AIP; Samarska IV; Speel EM; Riedl RG; Goudkade D; de Bruïne AP; Wouda S; van Marion AM; Verlinden IV; van Lijnschoten I; Friederich P; Winnepenninckx VJL; Zur Hausen A; Sciot RME; van den Hout MFCM
    Histopathology; 2024 Apr; 84(5):794-809. PubMed ID: 38155480
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extrapulmonary inflammatory myofibroblastic tumor (inflammatory pseudotumor). A clinicopathologic and immunohistochemical study of 84 cases.
    Coffin CM; Watterson J; Priest JR; Dehner LP
    Am J Surg Pathol; 1995 Aug; 19(8):859-72. PubMed ID: 7611533
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An inflammatory myofibroblastic tumour of the breast with ALK overexpression.
    Zhou Y; Zhu J; Zhang Y; Jiang J; Jia M
    BMJ Case Rep; 2013 Feb; 2013():. PubMed ID: 23386486
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spectrum of kinase gene rearrangements in a large series of paediatric inflammatory myofibroblastic tumours.
    Preobrazhenskaya EV; Suleymanova AM; Bizin IV; Zagrebin FA; Romanko AA; Saitova ES; Mulkidzhan RS; Imyanitov EN
    Histopathology; 2023 Jul; 83(1):109-115. PubMed ID: 37071060
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fusion of the ALK gene to the clathrin heavy chain gene, CLTC, in inflammatory myofibroblastic tumor.
    Bridge JA; Kanamori M; Ma Z; Pickering D; Hill DA; Lydiatt W; Lui MY; Colleoni GW; Antonescu CR; Ladanyi M; Morris SW
    Am J Pathol; 2001 Aug; 159(2):411-5. PubMed ID: 11485898
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inflammatory myofibroblastic tumor of the lung in children: anaplastic lymphoma kinase (ALK) expression and clinico-pathological correlation.
    Siminovich M; Galluzzo L; López J; Lubieniecki F; de Dávila MT
    Pediatr Dev Pathol; 2012; 15(3):179-86. PubMed ID: 22280150
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinicopathological features of inflammatory myofibroblastic tumor].
    Zhu Y; Ding Y; Song GX; Li X; Ding R; Fan QH; Gong QX
    Zhonghua Bing Li Xue Za Zhi; 2021 Mar; 50(3):194-200. PubMed ID: 33677881
    [No Abstract]   [Full Text] [Related]  

  • 39. Pediatric inflammatory myofibroblastic tumor: anaplastic lymphoma kinase (ALK) expression and prognosis.
    Chun YS; Wang L; Nascimento AG; Moir CR; Rodeberg DA
    Pediatr Blood Cancer; 2005 Nov; 45(6):796-801. PubMed ID: 15602716
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inflammatory myofibroblastic tumor of bone harboring an ALK gene amplification.
    Wang K; Guo R; Siegal GP; Wei S
    Pathol Res Pract; 2019 Sep; 215(9):152535. PubMed ID: 31326196
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.